Abstract

Background/Aims: The use of antibiotics to eliminate Mycoplasma contamination has some serious limitations. Mycoplasma contamination can be eliminated by intraperitoneal injection of BALB/c mice with contaminated cells combined with screening monoclonal cells. However, in vivo passage in mice after injection with contaminated cells requires a long duration (20–54 days). Furthermore, it is important to monitor for cross-contamination of mouse and human cells, xenotropic murine leukemia virus-related virus (XMRV) infection, and altered cell function after the in vivo treatment. The present study aimed to validate a reliable and simplified method to eliminate mycoplasma contamination from human hepatocytes. BALB/c mice were injected with paraffin oil prior to injection with cells, in order to shorten duration of intraperitoneal passage. Cross-contamination of mouse and human cells, XMRV infection and cell function-related genes and proteins were also evaluated.Methods: PCR and DNA sequencing were used to confirm Mycoplasma hyorhinis (M. hyorhinis) contamination in human hepatocyte C3A cells. Five BALB/c mice were intraperitoneally injected with 0.5 ml paraffin oil 1 week before injection of the cells. The mice were then intraperitoneally injected with C3A hepatocytes (5.0 × 106/ml) contaminated with M. hyorhinis (6.2 ± 2.2 × 108 CFU/ml). Ascites were collected for monoclonal cell screening on the 14th day after injection of contaminated cells. Elimination of mycoplasma from cells was determined by PCR and Transmission Electron Microscopy (TEM). Human–mouse cell and XMRV contamination were also detected by PCR. Quantitative reverse transcription PCR and western blotting were used to compare the expression of genes and proteins among treated cells, non-treated infected cells, and uninfected cells.Results: Fourteen days after injection with cells, 4 of the 5 mice had ascites. Hepatocyte colonies extracted from the ascites of four mice were all mycoplasma-free. There was no cell cross-contamination or XMRV infection in treated cell cultures. Elimination of Mycoplasma resulted in partial or complete recovery in the expression of ALB, TF, and CYP3A4 genes as well as proteins. Proliferation of the treated cells was not significantly affected by this management.Conclusion: The method of elimination of Mycoplasma contamination in this study was validated and reproducible. Success was achieved in four of five cases examined. Compared to the previous studies, the duration of intraperitoneal passage in this study was significantly shorter.

Highlights

  • Mycoplasma contamination of cultured cells poses a serious challenge to biological and biopharmaceutical studies, since infection rates of cell cultures can range from 15 to 100% (Kazemiha et al, 2016)

  • Non-treated contaminated cells cultured for 6 days after being thawed were designated as 1d M(+) cells, and non-infected cells were designated as M(−) cells. 1d M(+) cells which were further cultured in vitro for 43 days were designated as 43d M(+) cells

  • Mycoplasma infection is an insidious problem in mammalian cell culture (Gedye et al, 2015), it can be eliminated by in vitro and in vivo management

Read more

Summary

Introduction

Mycoplasma contamination of cultured cells poses a serious challenge to biological and biopharmaceutical studies, since infection rates of cell cultures can range from 15 to 100% (Kazemiha et al, 2016). A number of methods have been evaluated to eliminate Mycoplasma contamination, treatment of cell cultures with antibiotics remains the most widely used because it is simple and rapid (Drexler and Uphoff, 2002; Hopfe et al, 2013). Using antibiotics to eliminate Mycoplasma contamination has some serious limitations. Some antibiotics, such as aminoglycosides and lincosamides are effective at eradicating Mycoplasma contamination, they are cytotoxic to the cultured cells (Drexler and Uphoff, 2002; Laleh Nikfarjam, 2012). Recent data suggested that some antiMycoplasma antibiotics are mostly effective in the extracellular media and not as much against intracellular Mycoplasma (Degeling et al, 2012)

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.